ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Murray Copeland Display Dedicated

March 18, 1983

Centers Of Excellence In Interventions Aimed at molecular Targets; Approved On 19-6 Vote

July 2, 1999

With Flashing Lights, Heckling, and Folk Song, Avastin Sets New Tone for FDA Debates

July 1, 2011

An Earmark For Pancreatic Cancer

August 3, 2012

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

November 30, 2012